DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Abdulqawi R, Dockry R, Holt K. et al.
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.
The Lancet 2015;
385: 1198-1205
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.